Clinical trial
A Prospective Randomized Controlled Study on the Effects of Enhanced External Counterpulsation Combined With Cardiac Rehabilitation on Cardiac Function and Exercise Capacity in Patients With Atrial Fibrillation
NCT07058987 is registered in ClinicalTrials.gov with Lanzhou University Second Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective Randomized Controlled Study on the Effects of Enhanced External Counterpulsation Combined With Cardiac Rehabilitation on Cardiac Function and Exercise Capacity in Patients With Atrial Fibrillation
- Lead sponsor
- Lanzhou University Second Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- July 15, 2025
- Completion date
- March 31, 2026
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), cardiac rehabilitation, heart failure (hf)